Inventor profile of:

Philip E. Thorpe

City:

Dallas, Texas

Country:

United States

Published Applications:

45

Last publication date:

2016-07-14

Top Assignees for applications by Philip E. Thorpe

The entities that hold a legal rights for patent applications filed by inventor Thorpe Philip E.:

Recent patent applications by Thorpe Philip E.

Philip E. Thorpe from Dallas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-07-14
US20160199509A1
Human necessities

Cancer Treatment Comprising Therapeutics That Bind to Phosphatidylserine

#2 | 2016-05-26
US20160144061A1
Human necessities

Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides

#3 | 2016-01-21
US20160015826A1
Human necessities

Constructs Binding to Phosphatidylserine and Their Use in Disease Treatment and Imaging

#4 | 2015-08-27
US20150241431A1
Physics

Methods and compositions for isolating exosomes

#5 | 2015-05-14
US20150132220A1
Human necessities

Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides

#6 | 2014-10-30
US20140322134A1
Human necessities

Treating macular degeneration using antibodies to aminophospholipids

#7 | 2014-07-24
US20140205544A1
Human necessities

Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine

#8 | 2014-06-12
US20140161724A1
Human necessities

Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides

#9 | 2014-03-06
US20140065148A1
Human necessities

TREATMENT METHODS USING ANTIBODIES TO AMINOPHOSPHOLIPIDS

#10 | 2013-09-19
US20130243756A1
Human necessities

Methods for Treating Diseases and HSV Using Antibodies to Aminophospholipids

#11 | 2012-06-28
US20120164071A1
Human necessities

Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

#12 | 2012-03-15
US20120064037A1
Human necessities

Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids

#13 | 2011-05-31
US9573835
-

Tissue factor compositions and kits for coagulation and tumor treatment

#14 | 2011-03-15
US10642060
-

Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

#15 | 2011-02-10
US20110033454A1
Human necessities

Methods For Treating Diseases Using Antibodies to Aminophospolipids

#16 | 2011-02-01
US10642059
-

Compositions comprising cell-impermeant duramycin derivatives

#17 | 2010-12-09
US20100310638A1
Human necessities

Liposomes comprising duramycin and anti-viral agents

#18 | 2010-09-07
US10642119
-

Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids

#19 | 2010-03-16
US10642064
-

Liposomes coated with selected antibodies that bind to aminophospholipids

#20 | 2009-11-10
US10642099
-

Selected immunoconjugates for binding to aminophospholipids

#21 | 2009-11-03
US10642124
-

Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

#22 | 2009-08-11
US10621269
-

Selected antibody compositions for binding to aminophospholipids

#23 | 2009-07-30
US20090191121A1
Human necessities

Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids

#24 | 2008-11-25
US10642120
-

Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

#25 | 2008-09-09
US9998833
-

Combined cancer treatment methods using antibodies to aminophospholipids

#26 | 2008-05-27
US10642117
-

Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

#27 | 2007-07-24
US10642118
-

Selected antibody CDRs for binding to aminophospholipids

#28 | 2006-10-24
US9738970
-

Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

#29 | 2006-10-12
US20060228299A1
Chemistry; metallurgy

Constructs binding to phosphatidylserine and their use in disease treatment

#30 | 2006-09-26
US10376194
-

Combined methods and compositions for tumor vasculature targeting and tumor treatment

#31 | 2006-09-21
US20060210473A1
Chemistry; metallurgy

VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment

#32 | 2006-09-05
US10375741
-

Combined tissue factor methods for coagulation and tumor treatment

#33 | 2006-06-29
US20060141545A1
Human necessities

Cancer treatment kits using antibodies to aminophospholipids

#34 | 2006-06-27
US9351149
-

Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

#35 | 2006-06-06
US10373561
-

Antibody methods for selectively inhibiting VEGF

#36 | 2006-04-20
US20060083745A1
Human necessities

Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids

#37 | 2005-06-23
US20050136059A1
Human necessities

Cancer treatment methods using selected antibodies to aminophospholipids

#38 | 2005-06-16
US20050129696A1
Human necessities

Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

#39 | 2005-06-09
US20050123537A1
Chemistry; metallurgy

Antibody conjugate methods for selectively inhibiting VEGF

#40 | 2005-05-03
US9562245
-

Antibody kits for selectively inhibiting VEGF

#41 | 2005-04-28
US20050089523A1
Human necessities

Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

#42 | 2005-03-17
US20050059578A1
Human necessities

Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

#43 | 2005-02-10
US20050031620A1
Human necessities

Combined cancer treatment methods using selected antibodies to aminophospholipids

#44 | 2005-02-03
US20050025761A1
Human necessities

Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

#45 | 2005-01-06
US20050002941A1
Human necessities

Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

InventorID:

443621 ⎘